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Context: Patients with critical illness are thought to be at risk of adrenal insufficiency. There 
are no models of dynamic hypothalamic-pituitary-adrenal (HPA) axis function in this group 
of patients and thus current methods of diagnosis are based on aggregated, static models. 
Objective: To characterise the secretory dynamics of the HPA axis in the critically ill after 
cardiac surgery. 
Design: Mathematical modelling of cohorts.  
Setting: Cardiac critical care unit 
Patients/Subjects: 20 male patients critically ill (CI) at least 48 hours after cardiac surgery 
and 19 healthy (H) male volunteers. 
Interventions: None 
Main Outcome Measures: Measures of hormone secretory dynamics were generated from 
serum adrenocorticotrophic hormone (ACTH) sampled every hour and total cortisol every 
10-minutes for 24-hours.  
Results: All critically ill patients had pulsatile ACTH and cortisol profiles. Critically ill patients 
had similar ACTH secretion (1036.4(737.6)pg/ml/24hrs) compared to the healthy volunteers 
(1502.3(1152.2)pg/ml/24hrs, p=0.2), but increased cortisol secretion (CI:14447.0(5709.3) v 
H:5915.5(1686.7)nmol/L/24hrs, p<0.0001). This increase in cortisol was due to non-pulsatile 
(CI:9253.4(3348.8) v H:960(589.0)nmol/L/24hrs, p<0.0001), rather than pulsatile cortisol 
secretion (CI:5193.1(3018.5) v H:4955.1(1753.6)nmol/L/24hrs, p=0.43). Seven (35%) of the 
20 CI patients had cortisol pulse nadirs below the current international guideline threshold 
for Critical Illness Related Corticosteroid Insufficiency, but an overall secretion that would 
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Conclusions: This study supports the premise that current tests of HPA axis function are 
unhelpful in the diagnosis of adrenal insufficiency in the critically ill. The reduced ACTH and 
increase in non-pulsatile cortisol secretion imply that the secretion of cortisol is driven by 
factors outside the HPA-axis in critical illness. 
 
Precis: We present 24-hour ACTH / cortisol profiles in patients critically ill after cardiac 
surgery and show both hormones are pulsatile. Using mathematical modelling to derive 
secretory dynamics, we suggest that current methods of diagnosing adrenal insufficiency in 












Critical illness and multi-organ failure present a major inflammatory challenge to human 
physiology. Patients with critical illness require specialist management in a critical care / 
intensive care unit - an area which has a sole function to provide advanced monitoring or 
support to single or multiple body systems. Patients who are critically ill after cardiac 
surgery represent an important cohort for study since the inflammatory stimulus is better  
defined  than in most other critically ill patients. Its onset time also is exactly known – 
allowing a standardised timeline to be drawn. The systemic inflammatory response of the 
individual is not stylised however;  whilst over 98% of patients survive cardiac surgery(1) -  
75% of patients will have only a short  (<2 days) stay in a critical care unit. Twenty percent 
will have a moderately extended stay and around 3% will have a long (>10days) stay(2). One 
of the key physiological systems that regulates the inflammatory response is the 
hypothalamic-pituitary-adrenal (HPA) axis. Both excess and deficiency(3) of components of 
the system have been shown to be associated with poor patient outcomes.  Developing 
thresholds of normality  for these has stalled(4), primarily as there is no accurate model for 
HPA-axis function in critical illness that encompasses the dynamic and pulsatile nature of 
the system. The term “critical illness related corticosteroid insufficiency - (CIRCI)”(4,5) has 
been coined to describe patients who clinicians believe do not produce sufficient 
corticosteroids during their critical illness.  
 
 
Adrenocorticotropic hormone (ACTH) released from the anterior pituitary (in response to 
portal blood corticotrophin releasing hormone (CRH) and arginine vasopressin (AVP)) acts 
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to synthesise cortisol de novo creates a feedforward delay in the release of cortisol, while 
secreted cortisol then has a negative feedback effect both on the pituitary and the 
hypothalamus to reduce release of ACTH. This positive feed-forward and negative feed-back 
with delay causes the secretion of both ACTH and cortisol to oscillate with a wavelength of 
around an hour in health(6,7). These secretory pulses of cortisol form an ultradian 
rhythm(8). In health, this ultradian rhythm underlies the circadian rhythm. The peak of the 
circadian rhythm is formed by large amplitude pulses and the nadir occurs at a time of little 
or no pulsatile activity(9). 
Pulsatility is important for glucocorticoid signalling, and mammalian cells have developed 
tissue specific mechanisms to decode these oscillating signals. Multiple genes are 
differentially activated or inhibited depending on whether the signal is pulsatile or constant 
– even when the total dose is the same(10,11). It has been shown that there is an initial rise 
in both hormones for the first day of critical illness and that cortisol remains high, whilst 
ACTH subsequently falls – so called ‘dissociation’. Previous studies in critical illness have 
been sampled too infrequently to appreciate any pulsatility and therefore define the 
interaction between ACTH and cortisol(12).  
This study was designed to help develop a model of HPA-axis function in critical illness by 
characterizing the serum hormonal patterns of ACTH and cortisol as well as understanding 
the secretory patterns that underlie them. 
 
Materials and Methods 
The study was reviewed and approved by the National Health Service (NHS) National 
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Boards of the respective centres. Incapacitated patients were recruited with deferred 
consent. Healthy volunteers provided written, informed consent. Female sex hormone 
cycles are known to affect the HPA-axis(13) and for this reason, female participants were 
excluded. 
 
Subjects – Critical care patients 
Twenty patients were recruited from a single cardiac critical care unit and met all of the 
following inclusion criteria: 1. Male, 2. Ages 18 – 80 having undergone elective or 
emergency cardiac surgery, 3. Post-operative day 2 or later (to exclude the immediate 
inflammatory effects of the surgery), 4. At the start of sampling, the patient was receiving at 
least 2 of the following: a) Invasive mechanical ventilation, b) Inotropes and/or vasopressors 
and/or c) Haemo(dia)filtration. Patients were excluded if they met any of the following 
exclusion criteria: 1. Current or recent (< 3 months) use of glucocorticoids, 2. Disorders of 
the HPA axis, 3. Thyroid disease, 4. Etomidate use at any stage of the surgical pathway. 
 
Subjects – Healthy controls 
Healthy males were recruited. Participants were eligible if: a complete medical history, 
physical examination, and screening tests of haematological, renal, hepatic, metabolic, and 
endocrine function were normal. Participants were excluded if they had recent (<10 days) 
trans-meridian travel, weight change (>2 kg in 6 weeks), shift work, intercurrent 
psychosocial stress, prescription medication use, substance abuse, neuropsychiatric illness, 
or acute or chronic systemic disease and also if they were exposed to exogenous 
glucocorticoids in the previous 3 months. Participants maintained conventional work and 
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sampling for adaptation. Vigorous exercise, daytime sleep, snacks, caffeinated beverages, 
and cigarette smoking were disallowed. Meals were provided at 0800, 1230, and 1730, and 
room lights were turned off between 2200 and 2400 depending upon individual sleeping 
habits. 
 
Collection and processing of blood samples – critically ill patients 
Patients had blood sampled for 24 hours via their in-situ vascular catheters from 0800hrs 
using a needle-free, closed loop sampling system (Edwards VAMP. Edwards Life Sciences 
Corp, Irvine, CA. USA). Total serum cortisol was sampled at 10-minute intervals. ACTH was 
sampled every hour due to limitations of blood volume sampling in patients already at risk 
of blood loss. Cortisol samples were collected in BD vacutainer SST Advance tubes (Becton, 
Dickinson and Company, Oxford. UK) and were processed immediately after centrifugation. 
Samples for ACTH were collected in chilled 2ml EDTA tubes and stored on ice for a 
maximum of 60 minutes before centrifugation at 4oC and then stored at -80oC until assay. 
Total cortisol and ACTH were measured by solid phase, chemo-luminescent enzyme linked 
immunoassay (ECLIA) using the Cobas e602 modular analyzer (Roche Diagnostics Ltd, West 
Sussex, UK). Measuring limits for the cortisol assay were 0.5 – 1750nmol/L (intra- and inter-
assay coefficients of variation (COV): 1.5 – 1.7% and 1.8 – 2.8% respectively) and for the 
ACTH assay were 1.0 – 2000 pg/ml (intra- and inter-assay COV: 0.6 – 2.7% and 3.5 – 5.4% 
respectively).   
 
Collection and processing of blood samples – healthy volunteers 
Venous blood samples were withdrawn at 10-min intervals for 24 hours. Sampling began 
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EDTA (for ACTH assay) or heparin (for cortisol assay), centrifuged at 4oC and frozen at - 20°C 
within 30 minutes of collection. Plasma ACTH concentrations were quantified in duplicate by 
high-sensitivity (3 ng/l) and high-specificity monoclonal immunoradiometric assay, using 
reagents from Nichols Diagnostics Institute (San Juan Capistrano, CA). Cortisol was assayed 
by high sensitivity (25 nmol/l) solid-phase RIA (Sorin Biomedica, Milan, Italy). Intra-assay and 
inter-assay COVs were 5.1 and 6.4%, respectively. No samples were undetectable in either 
assay.  
 
Statistical Analysis of Demographic Data 
Demographic data were compared between the critically ill patients and healthy volunteers 
using a t-test. 
 
Modelling Methodology 
Modelling of hormone secretory dynamics, ACTH – cortisol interaction and circadian rhythm 
was carried for each individual and then combined as summary statistics. Modelling and 
statistical analysis was carried out using user-developed programs in Matlab (Mathworks, 
Natick, MA).  
 
Cortisol and ACTH secretion rates are each modulated by time delayed concentrations of 
the other – it is this that is responsible for the pulsatility. Such feedforward and feedback 
are extremely difficult to estimate and implement overall. The best strategy has therfore 
previously been shown to estimate the kinetics and secretion rates of each hormone 
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a hormone at any given time is a balance of molecules being added and removed. The 
concentration (𝑋) at time t is: 




Z(s) is the secretion of a given hormone into the blood at time s.  E(t - s)  the fraction of 
molecules left at time t after molecules secreted at time s have exited the blood. The 
secretion rate is composed of two parts: a constant basal rate and a pulsatile non-basal 
component. To estimate the timing of the pulses: there is a pulse time set 
Tm = (T
(1),T (2),...,T (m-1),T (m)), where the number of pulse times (m) is unknown.  At each 
pulse time there is a secretory-burst with mass M (k )  described as a linear function of the 
preceding interpulse interval (T (k ) -T (k-1)), plus a random effect (𝑅(𝑘)) that allows for the 
biological variations in burst size that are not explicitly modelled by the linear function (e.g., 
desensitization, receptor or enzyme saturation). 
                               M




´ (T (k ) -T (k-1))+R(k )                                                       
𝜂0 denotes a minimum pulse amount and 𝜂1 is the rate of mass accumulation over the 
interpulse interval (T (k ) -T (k-1)).   The secretion rate is therefore:
 
          








)())(()( )()()1()(100                           
where 𝛽0 is the basal rate and 𝜓(𝑠) is a waveform of mass release (mass/unit volume/unit 
time) beginning at each pulse time.  To accommodate circadian rhythm modulation of the 
secretion rate, we allow for “day-night” differences in the waveform (one for day, one for 
night).  It was assumed that each is a (normalized) three parameter Gamma density.  
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Previous work has shown that a single elimination model tends to underestimate the 
elimination and overestimate the secretion - thus two elimination rates were used in this 
study: a fast and a slow rate(15).  The fast rate represents the advection, diffusion and 
mixing effects that the molecules undergo as the just secreted molecules diffuse, flow and 
become well mixed.  The slow rate represents elimination from the blood.  A widely applied 
pulse detection algorithm was used to recognise hormone pulses(14,15). An example of the 
application of the pulse detection and estimation of the ACTH and cortisol secretion and 
kinetics, to an individual’s profile, are contained in Fig 1. What is then observed is a time 
sampling of the concentration 𝑋(𝑡𝑖) , with measurement error: 
                           ),()( itXY ii    i=1,…,n ,                                                                           
where the errors were assumed to be independently and identically distributed (IID) normal 
with mean zero and variance 2
 .    A Gaussian (log) likelihood can then be written and 
penalized maximum likelihood estimation is performed (the penalty term is an Akaike 
Information Criterion (AIC) penalization on the number (m) and locations of the pulse 
times): Tm = (T
(1),T (2),...,T (m-1),T (m))).  The pulse detection procedure is part of the 
sequential estimation. An example is seen in the ACTH concentration profile for Critically Ill 
(CI) subject 1 (Fig 1a, top row).  
 
ACTH values in the critically ill group were measured hourly and were linearly interpolated 
to the 10-minute values, in order to be on the same scale as the corresponding cortisol 
values. Summary statistics for ACTH and cortisol were calculated over the full 24 hours. 
These included hormone pulse frequency and pulse regularity (interpulse variability)(16); 
total secretion, total pulsatile secretion, total basal secretion and mass per pulse (total 
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minutes; cortisol: 2.41 minutes) and the slow half-lives were estimated.  The values for the 
slow half-lives for ACTH were: Critically ill (Mean 23.06 minutes, Standard deviation (SD) 
6.81, Standard error of the mean (SEM) 1.56) and healthy volunteers (Mean 23.55 minutes, 
SD 7.72, SEM 1.77). The values for the slow half-lives for cortisol were: Critically ill (Mean 
53.60 minutes, SD 8.51, SEM 1.95) and healthy volunteers (Mean 56.16 minutes, SD 8.85, 
SEM 2.03). 
 
Once the two estimated secretion rates and pulse times for ACTH and cortisol have been 
determined for each subject, the ACTH drive on cortisol secretion was determined for each 
individual subject and then grouped.  Four dose-response models of cortisol secretion (as a 
pulse-by-pulse function) of ACTH drive were considered. A fundamental difficulty in 
modelling endocrine dose-response interactions is the inherent biological variation 
(desensitization, receptor and enzyme saturation) and thus hysteresis occurs.  Hysteresis 
refers to a change in cortisol responsiveness to an ACTH pulse.  Three such models of ACTH 
– cortisol interaction incorporating hysteresis are considered (a shift in potency, sensitivity 
or efficacy), as well as a model of no hysteresis(17). A schematic of the models is presented 
in Fig 2. 
 
Based upon the individual modelling of ACTH (e.g. as seen in Fig 1), the fitted ACTH 
concentrations were obtained for each subject. These values were the basis for the ACTH 
feedforward signal on cortisol secretion.  Similarly, from the model of cortisol secretion (an 
example is seen in Fig 1) we obtain the estimated cortisol secretion rate for each subject. 
The variable time delay and biological variation (e.g., desensitization) from ACTH drive 












Time delay: The ACTH feedforward signal was constructed piecewise, from one Cortisol 
pulse onset time to the next, thus allowing for a varying time lag between an ACTH pulse 
onset and a Cortisol pulse onset. For each Cortisol pulse time, the ACTH pulse nearest within 
the allowable time, [-60,10] min, was identified.  If such an ACTH pulse existed, then it was 
shifted to the Cortisol onset point so that the two onset points are aligned.  If no such pulse 
existed within the time interval, then a time lag of 40 min was applied to the ACTH 
concentrations, starting at the Cortisol pulse onset time.  We also allowed for the possibility 
that the ACTH pulse may slightly (10 min) follow the Cortisol pulse, due to neural 
innervations.   
 
Biological variation: Pulse-by-pulse random effects in the efficacy of the logistic dose-
response function are included and we allowed hysteresis to occur, via a mid-(ACTH) pulse 
shift in the dose response. Specifically, the Cortisol response on the upswing of an ACTH 
pulse, is allowed to change on the downswing.  Hence, a hysteresis-like phenomenon 
occurs, with the system resetting (given sufficient time) to the initial curve, ready for the 
next secretory pulse(18).  An example of estimation for one individual is given in Fig 3. 
 
Statistical Analysis of Four ACTH-cortisol Dose-Response Models:  In Model 1 (No-
Hysteresis) there are six variables as outcomes: Potency, Sensitivity, Efficacy, Baseline, as 
well as the error variance and the Random Effects variance.  In Models 2 - 4, there are eight 
outcome variables, with the additional two variables being: a. the estimated ACTH 
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sensitivity and efficacy values, post hysteresis onset. Wilcoxon Ranksum test and the two-
sample T test were used to compare the models.  
 
Statistical Modelling of Circadian Rhythms:   Estimation of the ACTH and cortisol circadian 
rhythms was achieved by modelling their secretory pulse time patterns, as described above 
(seen in Fig 1). Estimated secretory pulse times for both ACTH and cortisol were calculated 
and then a Gaussian kernel-smoothing algorithm was applied to estimate the time-varying 
pulse rates for each group. As a measure of a loss of circadian rhythm, the maximum minus 
the minimum of each curve was calculated and compared between the groups. The pulse 
rate for both ACTH and cortisol were estimated to obtain measures of accuracy of the 
estimates of circadian rhythm loss.  A Gaussian kernel-smoothing algorithm was applied to 
estimate the time-varying ACTH and Cortisol pulse rate for each group.  To examine the 
variation in these loss of CR calculations (as if repeated experiments were performed) a 
resampling procedure was constructed.  A leave 2 out, including 1 out, if chosen twice 
(which is a 10% resampling rate) was applied.  Hence, an estimate of the probability 
distribution for each of the pulse rate functions (ACTH and cortisol) for the CI and H groups 
was obtained. To estimate the Loss of Circadian Rhythm for the hormone, a random pulse 
rate for the CI group and from the H group are selected.  The difference between the 
maximum and the minimum is calculated for each. The ratio of the CI difference to the H 
difference is calculated, and one minus this ratio is one (random) observation for loss of 
circadian rhythm.  This was repeated 1000 times.  By construction, this is precisely the 
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Complete 24-hour profiles for cortisol were available for 20 critically ill patients and 
complete ACTH profiles were available for 19/20 patients. Index operations were: 6 isolated 
CABG, 3 isolated valve replacements, 2 single valve replacements  , 3 combined CABG and 
valve replacements, 1 replacement of the thoracic part of the aorta, 3 valve replacements 
and replacement of thoracic part of aorta, 1 CABG and replacement of thoracic part of the 
aorta and 2 operations that did not fit these categories. Seven (35%) of these operations 
were carried out as emergencies (requiring surgery before the start of the next working 
day).  One patient died 30 minutes before the end of the 24-hour sampling period. Data for 
this patient were included up until the point of death. There were 19 healthy controls with 
both ACTH and cortisol profiles available. Therefore, in the analysis of ACTH alone, there 
were 19 subjects, and for cortisol alone, there were 20 subjects; in the joint analysis of ACTH 
and cortisol, there were 19 subjects. 
 
Characteristics 
Baseline characteristics for both groups are shown in Table 1 and post-operative 
characteristics are shown in Table 2.  Critically ill patients were on average twenty years 
older and had a greater body mass index than healthy volunteers. All critically ill patients 
were mechanically ventilated following surgery and all except one were receiving treatment 
with intravenous vasopressors or inotropes. 
 
ACTH and Cortisol profiles and secretory patterns 
Twenty-four-hour profiles of serum ACTH and cortisol were pulsatile in both the critically ill 
and healthy volunteer groups (Examples of individuals are given in Fig 4 and by group(19)). 
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patient who died towards the end of the sampling period. This patient also lost pulsatility 
before death. Seven of the 20 critically ill patients (35%) had cortisol pulse nadirs that were 
below the international guideline threshold for the diagnosis of CIRCI (10mcg/dl / 
276nmol/L)(5). 
 
Measures of secretory dynamics are shown in Table 3. The pulse rates and regularity of both 
ACTH and cortisol were similar between both the critically ill and the healthy volunteer 
groups. The total secretion of ACTH was statistically similar in the two groups, as was the 
amount of pulsatile ACTH secretion and the basal (non-pulsatile) ACTH secretion. The mass 
of ACTH released per pulse was similar between the two groups. There were differences in 
cortisol secretion - total cortisol secretion was significantly increased in the critically ill 
group and all of this increase appears to come from basal (non-pulsatile secretion). The 
amount of cortisol secretion that is pulsatile is broadly similar between the two groups; in 
terms of pulse rate, regularity and mass of cortisol per pulse.   
 
ACTH-cortisol interaction 
The results from all models are shown in Fig 5 and show that in the critically ill group, the 
adrenal glands are more sensitive to ACTH, but with reduced efficacy and similar potency 
(i.e. the ACTH-cortisol dose-response curve is steeper but reaches a lower maximum 
response). All models show a significant increase in the sensitivity of the adrenal glands as 
characterised by ACTH-cortisol dose-response. In the models encompassing hysteresis, the 
efficacy (i.e., ability to produce the maximal cortisol output) of ACTH was reduced in the 
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cortisol secretion in the critically ill group, as well as less random variation in the critically ill 
group. There were no differences in random effects variances in any of the models.  
 
Circadian rhythm 
There was a reduction in circadian variation of both ACTH and cortisol (See Fig 6). The 
reduction in circadian variation of the critically ill group of ACTH was by a median 51% and 
cortisol by median 74% when compared to the healthy volunteers. The lower quartile, 
median and upper quartile, for each distribution of the difference between maximum and 
minimum of the time varying pulse-rates per 24 hour period was for ACTH: (CI): 2.8, 3.0, 3.3; 
(H): 6.0, 6.2, 6.4; and for cortisol: (CI): 1.1, 1.3, 1.6; (H): 5.0, 5.2, 5.5.  The lower, median and 
upper quartile of the distributions of a loss of Circadian Rhythm in the Critically ill compared 




The HPA-axis is frequently tested by clinicians on critical care units using a single-point 
serum sample or stimulation with synthetic ACTH. The results of these tests are used to 
determine the need for administration of synthetic corticosteroids to patients who are 
deemed to be ‘deficient’ – so called Critical Illness Related Corticosteroid Insufficiency 
(CIRCI)(4,5). There is currently no model of HPA-axis function during critical illness that takes 
into account the dynamic, pulsatile nature of this system. This has made delineating the 
thresholds for deficiency and ‘excess’ almost impossible. There is also no clear evidence-
based treatment regimen for cortisol replacement or supplementation in critical illness(20) 
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activation or inhibition of glucocorticoid responsive genes(10,11,21). In this study, we used 
high-frequency sampling of both ACTH and cortisol for a 24-hour period to study the profiles 
and elicit the dynamic interaction of both these hormones in critically ill patients after 
cardiac surgery and compared them to a cohort of healthy volunteers. 
 
The most striking result was that the profiles of both ACTH and cortisol in the critically ill 
patients remained pulsatile with concordance between the pulses of ACTH and cortisol 
throughout the 24-hour period. The observed pulsatility fits with previously studied 
examples of chronic illness such as obstructive sleep apnoea(22), coronary artery 
surgery(23) and a nocturnal only study of critical illness(24).  
 
The results illustrate why single point testing of cortisol in critically ill patients lacks 
specificity and is unhelpful in diagnosing CIRCI if such a syndrome exists. Seven of the 20 
patients (35%) had cortisol pulse nadirs that were below the international guideline 
threshold for the diagnosis of CIRCI (10mcg/dl / 276nmol/L)(5), even though a subsequent 
pulse peak would be markedly above this threshold. This concurs with previous work that 
shows that a single-point test of cortisol in the 24-hour peri-operative period of cardiac 
surgery is not predictive of the cortisol value even 40 minutes later(25). Furthermore, 
previous models of HPA axis function have been derived from aggregated patient data.  
Aggregated profiles of pulsatile hormones lead to smooth curves – thus there is a situation 
in which the aggregated model of HPA axis function currently used for diagnosis of adrenal 
suppression in the critically ill, represents virtually no individuals in that population. 
Techniques aiming to circumvent the problems of point testing of serum cortisol and derive 
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multiple frequent samples have included measuring cortisol in the saliva(26) and urine(27). 
Salivary cortisol has not been  recommended(5) due to it failing to demonstrate any benefit 
in patient outcomes, but more importantly; practically collecting samples of saliva in 
critically ill patients is difficult, as they often do not produce sufficient volumes for 
assay(26). This is similar to urinary cortisol; critically ill patients have a markedly reduced 
glomerular filtration rate (GFR) and many will be receiving renal replacement therapy (8/20 
patients in this case). Free cortisol excretion is dependent on the GFR and therefore using 
urine in the critically ill is not useful (28). The new development of  frequent cortisol 
sampling by microdialysis  from the subcutaneous tissue(27) has not yet been tested in 
critical care. It will be interesting to see this type of data in critically ill patients as the data 
will reflect the levels of free cortisol in the tissues rather than total cortisol in the blood. 
 
Because pulsatility emerges as a consequence of the feedforward-feedback interaction of 
ACTH and cortisol(6,29), our data implies that the pituitary-adrenal connection remains  
intact in critical illness and that there is no ‘disconnect’(30) between these two hormones. 
The sensitivity of the interaction is changed however; the adrenal gland is more sensitive to 
ACTH in critical illness. ACTH has a reduced efficacy and similar potency when compared to 
healthy individuals. i.e. the dose-response curve for ACTH-cortisol starts at the same point 
(similar potency) but is steeper (more sensitive) and reaches a lower maximum (reduced 
efficacy) than in healthy individuals. The increased adrenal sensitivity seen immediately 
after cardiac surgery appears to be related in part to increased expression of the ACTH 
receptor accessory protein, MRAP(23), but we could not test this hypothesis in this study. 
Other mechanisms mediating this increased adrenal sensitivity and elevated cortisol 
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such as IL1, IL6 and TNF-α(30). Receptors for these on zona fasciculata cells are able to 
stimulate cortisol production in a dose-dependent manner. Activity of the splanchnic nerves 
can also modulate  adrenal production of cortisol, and increase blood flow to the  adrenal 
gland - which is sufficient to increase cortisol secretion(31-33). In the setting of systemic 
inflammatory vasodilation, it seems likely that any additional effect of the splanchnic nerves 
would be minimal.   
 
All cortisol that is secreted needs to be synthesised de novo – its fat-soluble properties 
preclude its storage in vesicles. The rate limiting step of cortisol synthesis is the transport of 
cholesterol from the outer to the inner mitochondrial membrane by the Steroidogenic 
Acute Regulatory (StAR) protein. This is clearly a saturable process with a finite maximum 
rate. Therefore, although it appears that ACTH has a lower efficacy, this is in effect illusory, 
as the gland is starting at a higher secretion rate and thus any increase in secretion towards 
a fixed maximum would, of necessity be lower. The changed ACTH-cortisol dose-response 
also calls into question the use of the co-syntropin / short synacthen test to diagnose 
‘deficiency’ in critical illness using thresholds defined in health(34). 
 
There has been no previous study of a full 24-hour period of HPA axis hormone dynamics in 
critically ill patients, although short periods of pulsatility have been observed(24,35). The 
only similar study examined nocturnal cortisol and ACTH secretion rather than 24 hours. 
They also found that the number of pulses were not different between the healthy 
individuals and critically ill patients, but in contrast to our work they found that non-
pulsatile secretion of both ACTH and cortisol was the same between the two groups and 
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for the differences they found was reduced cortisol breakdown(36,37). Compared to the 
previous study, our group of critically ill patients was more homogenous – they were all 
critically ill after cardiac surgery and our sampling period was much more standardized in 
terms of the timescale of their critical illness. We deliberately avoided the first 48 hours 
after surgery to ensure that the effects we see were those of critical illness and not the 
immediate post-operative changes. The changes to the HPA-axis in critical illness are likely 
to change with time. There is a relatively short initial ACTH surge driving the cortisol 
secretion(23). ACTH is then suppressed by the high levels of cortisol and cortisol levels 
remain high. The loss of the trophic effect of ACTH in the longer term may lead to a 
reduction in activation of the adrenal gland to produce cortisol(24). Longer duration of 
critical illness is then likely to result in other changes, such as the previously described 
decreased cortisol metabolism (29,30).  Critical illness can be a progressive condition and 
therefore sampling at defined time-points in defined disease processes is important to truly 
understand the pathophysiology of changes in HPA-axis function. One of the advantages of 
using cardiac surgery to investigate the HPA-axis response to systemic inflammation is that 
the timeline can be standardized because the timing of the inflammatory stimulus is known. 
 
Although reduced circadian variation of HPA activity has been described in patients with 
critical illness(35,38), this had not been previously quantified and the differences between 
ACTH and cortisol variations have  not been compared. Blunting of the circadian rhythm in 
critical care units is not only a function of illness itself, but can also occur for a range of 
environmental and internal disturbances. Light (particularly low intensity blue) transmitted 
outside the visual pathways is the major stimulus that entrains circadian rhythms(39). The 
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less than that on an overcast day and around 1000 times less than a sunny day(40,41). Some 
of the blunting may be attributed to this, but it seems more likely that the inflammatory 
drive to the system overcomes the decrease in adrenal activation over the nocturnal 
nadir(35,36). 
 
This study has some limitations. First, ACTH could not be measured as frequently in the 
critically ill patients as the healthy volunteers due to the clinical team’s concern over blood 
loss in a cohort who were already at risk of transfusion. Secondly, we were unable to exactly 
match the critically ill and healthy volunteers for age and body habitus, although the 
changes in ultradian rhythm with age(42) and body mass index(43,44) are small. The 
secretory dynamics of ACTH and cortisol in this study are based on mathematical models 
and not direct experimentation. However, the results using these empirical models broadly 
correlate broadly with what has been found previously in critical illness using other 
techniques – that although the adrenal gland is more sensitive to ACTH(23), non-ACTH 
mechanisms drive the increased cortisol secretion(36) with ACTH being permissive. We used 
separate assays in the patients and the healthy volunteers due to the sampling being carried 
out on 2 separate sites. The laboratories of the hospital provide immediate access to 
automated   ACTH and cortisol assays which we utilized for the patients. Samples from 
volunteers in the clinical research facility were rapidly spun and frozen for subsequent 
assay. Although there is no direct comparison of  the two assays in studies of ECLIA versus 
RIA for both cortisol and ACTH, the r=0.9 (45,46) suggests good comparability of the 2 
assays. The population size was small and so establishing the effect of multiple interventions 
(vasoactive and other drugs, haemofilters and ventilators) used in critical care is not 
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associated with minimal cortisol loss from the plasma(47) and so for the 8/20 patients 
receiving this treatment modality, we can say that plasma concentrations of cortisol are not 
artificially suppressed. We did not include women in this study because practically, it would 
have been impossible to get a large enough sample size to allow for comparison of sex 
differences. This is due to around 75% of cardiac surgery in the UK being performed on 
men(1) (for the reason of higher rates of acquired heart disease in men – despite the 
changing profile of cardiac surgery from coronary artery bypass grafting to valve surgery). 
Our aim in this study was for homogeneity so as to allow us to make clear conclusions on 
the effects of critical illness. Now that we have this data we shall be able to include women. 
 
There are two questions that have dominated critical care research into HPA-axis 
function(4,5): i) Is there a group of patients who are deficient or relatively deficient in 
glucocorticoids in critical illness and ii) do supplementary glucocorticoids improve outcome 
in critical illness? These two questions are often confused, but future work is needed to 
answer them independently. To begin to answer the first question, we require a valid model 
of HPA-axis function in critical care that should encompass the dynamic interactions in HPA 
function and the temporal changes seen in critical illness . Ideally this should  also reflect the 
tissue activity of the cortisol(9), rather than surrogates in the blood. Until we produce this 
model, however, the safe answer to the second question is straightforward; those managing 
critically ill patients should give so-called ‘low-dose’ corticosteroids (<200mg/day) to all 
patients receiving at least modest doses of vasopressor without testing their adrenal 
function, as there is evidence that this positively impacts morbidity (but not mortality) with 
a low-risk of harm(20,48). This does not, of course, take into account the question raised by 
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that pulsatility is important for function. This has yet to been tested in critical care practice. 
Once we have a useful model of dynamic HPA-axis function, then we can design diagnostic 
and treatment strategies for the individual that produce maximum clinical effectiveness 
with the fewest adverse events. This is already being done for patients with chronic 
hypoadenalism (49-51), and these same techniques should now be brought to the critical 
care unit. 
 
This study has shown that both ACTH and cortisol are pulsatile in critical illness and the 
pulses are concordant. The elevated serum cortisol in critical illness clearly involves other 
adrenal sensitizing factors in addition to ACTH.  The nadir of cortisol pulses in 35% of the 
patients dropped below the threshold for deficiency in critical illness as defined by 
international guidelines, although values shortly before and shortly after would be well 
above this. This should stop the practice of point testing of cortisol in critical illness. The 
modelled alteration in the pharmacodynamics of ACTH in terms of cortisol response also 
calls into question the use of the co-syntropin test to diagnose deficiency, when the test 
thresholds are not derived from this population(34). A new model of HPA-axis function in 
critical care is required; encompassing the dynamic pituitary-adrenal interactions, as well as 
other factors such as inflammatory mediators. Once this has been generated, then we can 
move forward establishing if CIRCI exists and if so, develop appropriate diagnostics and 
therapeutic interventions based on that model. 
 
Data Availability 
The datasets generated during and/or analyzed during the current study are not publicly 
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Figure Legends 
Fig 1. Graphs to show how the pulse detection algorithm was applied to individual hormone 
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the concentration profile local minima (red asterisks panel a. second row).  It then 
progressively and selectively smooths the profile, with the degree of smoothing being 
inversely related to its rate of increase. Panel a, row 3 displays the smoothed profile after 
3000 algorithmic steps (red asterisks are the corresponding remaining putative pulse times).  
Panel a, 4th row displays the potential pulse time sets (red asterisks) as the algorithm 
proceeds.  Hence, putative pulse times are progressively removed.  The number of pulse 
times is therefore between 21 pulses (panel a, row 3) and 10 pulses (panel a, 4th row).  The 
estimation algorithm then proceeds by estimating the secretory and elimination parameters 
for each potential pulse set (each horizontal collection of pulse times), with the number of 
such pulses being a penalizing term in penalized maximum likelihood estimation (PMLE).  Fig 
1b shows the result of the estimation.  In the top row, the observed concentration profile 
(solid blue) and its fitted profile (dashed red) are displayed, as well as the eleven (red 
asterisks) estimate pulses from the PMLE.  The 2nd row is the resulting estimated time-
evolving secretion rate.  The 3rd row are the two estimated waveforms of mass release (night 
- red, day - blue).  Statistics for the pattern of pulsing, based upon the estimated pulse times 
are calculated under the assumption that the pulse time process is a Weibull renewal 
process, a generalization that includes the Poisson process as a special case.  The Weibull 
model describes the inter-pulse interval lengths, allowing highly regular, as well as highly 
irregular pulsing patterns. The estimates summarize the resulting observed pulse time 
pattern.  In the 4th row of panel b is the estimated Weibull distribution for the interpulse 
intervals (observed interpulse = red asterisks).  The analogous results for the cortisol profile 
for CI subject 1 are given in Figure 1c-d. 
 












Fig 3. Example of how the dose-response models for ACTH – cortisol interaction were applied 
to one individual. In Fig. 3a(CI Subject 1) the top row is their estimated cortisol secretion 
rate, with the 2nd row consisting of the fitted ACTH concentration profile (red line) and the 
resulting ACTH feedforward signal (𝐹𝐴(𝑡) - green dashed line) for which the time-varying 
forward shifting has occurred, as a result of the ACTH and cortisol pulse times alignment.  On 
the time axis, the ACTH (asterix) and cortisol (diamonds) are plotted to elucidate the 
procedure.  In the bottom row of Fig 3a, all three of the above curves are superimposed to 
visualize the alignment of the ACTH feedforward signal and the cortisol secretion rate.  In Fig 
3b, the four estimated dose response models are displayed.  For the three hysteresis models 
(shift in either Potency, Sensitivity or Efficacy), there is a pulse-by-pulse random shift in the 
dose-response before hysteresis (blue dashed curves) and the corresponding plots after 
hysteresis (red dashed) curves; the solid blue and red curves are the mean pre- and post-
hysteresis dose-response functions.  For the Non-Hysteresis (NH) model, there is clearly only 
one set of pulse-by-pulse curves.  In Fig 3c, the fit (red dashed curve) of result of the four 
dose-response models to CI subject 1’s cortisol secretion rate (blue solid curve) is shown.  The 
Non-Hysteresis model does not capture the dynamic nature of cortisol, whereas the three 
hysteresis models do.   
 
Fig 4. 24-hour ACTH and cortisol profiles of one critically ill patient (top) and one healthy 
volunteer (bottom). Time points are every 10 minutes starting from 0800 in the critically ill 
patient and 0900 in the healthy volunteer. Note that the ACTH scale in the critically ill 









/dgz206/5628812 by guest on 26 February 2020
 
 33 
Fig 5. Summary diagram of the four models used to test the ACTH induced stimulation of 
cortisol secretion.  In each subplot, the values for each subject are displayed as black 
asterisks and the sample means are linearly connected (Red). A ± SEM is plotted about the 
mean (Red). 6a-d. The Four Models are: No Hysteresis (6a); Hysteresis with a Potency shift 
(6b); Hysteresis with a Sensitivity shift (6c); and Hysteresis with an Efficacy shift (6d).  Two 
statistical tests of a difference in their means were applied: Wilcoxon Ranksum test and the 
two-sample T test - when P-values are given, they are given in that order and are two-sided.    
 
Fig 6.  Graphs to show the loss of circadian rhythm in critically ill patients of ACTH and 
cortisol.    a.  The ACTH pulse times for each subject (horizontal rows) for the critically ill 
(Top) and healthy (Bottom) groups.   b.  The cortisol pulse times for each subject (horizontal 
rows) for the critically ill (Top) and healthy (Bottom) groups. All pulse times, in all subjects, 
are displayed on the baseline. c and d. The sampled rate functions for the critically ill (Left) 
and healthy volunteers (Middle) are plotted in (c) ACTH and (d) Cortisol. The panels on the 
right of (c) and (d) show the probability density for the loss of circadian rhythm for ACTH (c) 
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Table 1. Demographics of Critically Ill patients and Healthy Volunteers 
Demography Critically Ill (n = 20) Healthy (n = 19) P-value  
 
Age  
Years  Mean +/-SD 
63.9 +/-13.7 43.0 +/-11.6 <0.001 
Body Mass Index  
kg/m2   Mean +/-SD 
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Renal Replacement Therapy 
N (%) 
8 (40) 
Operation to 1st Sample interval 
Days Median (range) 
3 (2-13) 
ICU Length of Stay 
Days Median (range) 
18 (5 – 37) 
Acute Hospital Length of Stay 
Days Median (range) 
24 (7 – 44) 
Sequential Organ Failure (SOFA) Score 
Median (IQR) 
At sampling start 
9 (7-10) 
Albumin at sampling start 
g/dl Mean (SD) 
24.2 (5.0) 
 
Albumin at sampling end 
g/dl Mean (SD) 
22.45 (4.3) 
Cortisol Binding Globulin at sampling start 
mcg/ml Mean (SD) 
26.9 (12.4) 
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Cortisol Binding Globulin at sampling end 
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pulses / 24hrs 
13.08 (2.05) 







15.23 (2.82)  
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